Healthcare

Albertsons joins NationsBenefits’ network
Albertsons' partnership with NationsBenefits will expand access to essential groceries for Medicare Advantage members through the Benefits Pro Portal.
Global generic drugs market to reach $671.5B by 2030, report finds
Small-molecule generic drugs account for a lion's share of the market, while biosimilars exhibit fastest growth, per a new report from ReasearchAndMarkets.com.

U.S. health care evolving to become more personalized, consumer-focused, research finds

Trends that could impact the market’s future, include the potential for future pandemics, emerging advancements in healthcare technologies and an aging population.
Lupin debuts generic Myrbetriq

Myrbetriq is indicated for the treatment of overactive bladder.
Prioritizing Lower-Priced Biosimilar Medications

Legacy PBM business models are fundamentally misaligned with the needs and interests of plan sponsors and their members.
Watch DSN: EmpirRx Health focuses on a clinically driven model

Danny Sanchez, CEO of EmpirRx Health, discusses how it is different than other well-known PBMs and how the company puts patients first through its clinically driven model.
CVS Health invests $19.2M in affordable housing in Colorado

CVS Health's investment builds upon efforts to increase access to permanent supportive housing and to reduce homelessness.
NACDS lauds enactment of Oregon PBM reform bill

HB 4149 will provide Oregon with enforcement authority, requiring PBMs to be licensed by the Oregon Department of Consumer and Business Services starting Jan. 1, 2025.
Alvotech signs U.S. agreement to expand access for high-concentration interchangeable Humira biosimilar

Teva will continue to commercialize adalimumab-ryvk under the Simlandi brand in the U.S.
RevSpring debuts automated prescription refill, payments in one phone call

The new pharmacy self-service capabilities provide one integrated experience for patients to refill and pay.

Albertsons joins NationsBenefits’ network

Global generic drugs market to reach $671.5B by 2030, report finds

U.S. health care evolving to become more personalized, consumer-focused, research finds

Lupin debuts generic Myrbetriq

Prioritizing Lower-Priced Biosimilar Medications

Watch DSN: EmpirRx Health focuses on a clinically driven model

CVS Health invests $19.2M in affordable housing in Colorado

NACDS lauds enactment of Oregon PBM reform bill

Alvotech signs U.S. agreement to expand access for high-concentration interchangeable Humira biosimilar

RevSpring debuts automated prescription refill, payments in one phone call